The BRCA2 mutation status shapes the immune phenotype of prostate cancer

Defects in DNA damage repair caused by mutations in BRCA1/2, ATM or other genes have been shown to play an important role in the development and progression of prostate cancer. The influence of such mutations on anti-tumor immunity in prostate cancer, however, is largely unknown. To better understan...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Jenzer, Maximilian (VerfasserIn) , Keß, Peter (VerfasserIn) , Nientiedt, Cathleen (VerfasserIn) , Endris, Volker (VerfasserIn) , Kippenberger, Maximilian (VerfasserIn) , Leichsenring, Jonas (VerfasserIn) , Stögbauer, Fabian (VerfasserIn) , Haimes, Josh (VerfasserIn) , Mishkin, Skyler (VerfasserIn) , Kudlow, Brian (VerfasserIn) , Kaczorowski, Adam (VerfasserIn) , Zschäbitz, Stefanie (VerfasserIn) , Volckmar, Anna-Lena (VerfasserIn) , Sültmann, Holger (VerfasserIn) , Jäger, Dirk (VerfasserIn) , Duensing, Anette (VerfasserIn) , Schirmacher, Peter (VerfasserIn) , Hohenfellner, Markus (VerfasserIn) , Grüllich, Carsten (VerfasserIn) , Stenzinger, Albrecht (VerfasserIn) , Duensing, Stefan (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 23 September 2019
In: Cancer immunology immunotherapy
Year: 2019, Jahrgang: 68, Heft: 10, Pages: 1621-1633
ISSN:1432-0851
DOI:10.1007/s00262-019-02393-x
Online-Zugang:Verlag, Volltext: https://doi.org/10.1007/s00262-019-02393-x
Volltext
Verfasserangaben:Maximilian Jenzer, Peter Keß, Cathleen Nientiedt, Volker Endris, Maximilian Kippenberger, Jonas Leichsenring, Fabian Stögbauer, Josh Haimes, Skyler Mishkin, Brian Kudlow, Adam Kaczorowski, Stefanie Zschäbitz, Anna-Lena Volckmar, Holger Sültmann, Dirk Jäger, Anette Duensing, Peter Schirmacher, Markus Hohenfellner, Carsten Grüllich, Albrecht Stenzinger, Stefan Duensing

MARC

LEADER 00000caa a2200000 c 4500
001 1689231246
003 DE-627
005 20220817222246.0
007 cr uuu---uuuuu
008 200204s2019 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00262-019-02393-x  |2 doi 
035 |a (DE-627)1689231246 
035 |a (DE-599)KXP1689231246 
035 |a (OCoLC)1341303553 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
084 |a 33  |2 sdnb 
100 1 |a Jenzer, Maximilian  |e VerfasserIn  |0 (DE-588)1060844354  |0 (DE-627)802895565  |0 (DE-576)416970109  |4 aut 
245 1 4 |a The BRCA2 mutation status shapes the immune phenotype of prostate cancer  |c Maximilian Jenzer, Peter Keß, Cathleen Nientiedt, Volker Endris, Maximilian Kippenberger, Jonas Leichsenring, Fabian Stögbauer, Josh Haimes, Skyler Mishkin, Brian Kudlow, Adam Kaczorowski, Stefanie Zschäbitz, Anna-Lena Volckmar, Holger Sültmann, Dirk Jäger, Anette Duensing, Peter Schirmacher, Markus Hohenfellner, Carsten Grüllich, Albrecht Stenzinger, Stefan Duensing 
264 1 |c 23 September 2019 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 04.02.2020 
520 |a Defects in DNA damage repair caused by mutations in BRCA1/2, ATM or other genes have been shown to play an important role in the development and progression of prostate cancer. The influence of such mutations on anti-tumor immunity in prostate cancer, however, is largely unknown. To better understand the correlation between BRCA1/2 mutations and the immune phenotype in prostate cancer, we characterized the immune infiltrate of eight BRCA2-mutated tumors in comparison with eight BRCA1/2 wild-type patients by T-cell receptor sequencing and immunohistochemistry for CD45, CD4, CD8, FOXP3, and CD163. In addition, we analyzed seven prostate cancer biopsies that were either BRCA2 or ATM-mutated in comparison with wild-type tumors. Whereas in BRCA1/2 wild-type tumors, immune cells were found predominantly extratumorally, most BRCA2-mutated tumors including one biopsy showed a significantly increased intratumoral immune cell infiltration. The ratio of intratumoral to extratumoral immune cells was considerably higher in BRCA2-mutated tumors for all markers and reached statistical significance for CD4 (p = 0.007), CD8 (p = 0.006), and FOXP3 (p = 0.001). However, the intratumoral CD8 to FOXP3 ratio showed a trend to be lower in BRCA2-mutated tumors suggesting a more suppressed tumor immune microenvironment. Our findings provide a rationale for the future use of immune oncological approaches in BRCA2-mutated prostate cancer and may encourage efforts to target immunosuppressive T-cell populations to prime tumors for immunotherapy. 
700 1 |a Keß, Peter  |e VerfasserIn  |0 (DE-588)120409747X  |0 (DE-627)1689235012  |4 aut 
700 1 |a Nientiedt, Cathleen  |e VerfasserIn  |0 (DE-588)1162095288  |0 (DE-627)1025532813  |0 (DE-576)507145070  |4 aut 
700 1 |a Endris, Volker  |e VerfasserIn  |0 (DE-588)1063753686  |0 (DE-627)812590961  |0 (DE-576)422898198  |4 aut 
700 1 |a Kippenberger, Maximilian  |e VerfasserIn  |0 (DE-588)1204096996  |0 (DE-627)1689233702  |4 aut 
700 1 |a Leichsenring, Jonas  |d 1985-  |e VerfasserIn  |0 (DE-588)112053464X  |0 (DE-627)873481879  |0 (DE-576)480419272  |4 aut 
700 1 |a Stögbauer, Fabian  |d 1983-  |e VerfasserIn  |0 (DE-588)140241493  |0 (DE-627)618241841  |0 (DE-576)31658827X  |4 aut 
700 1 |a Haimes, Josh  |e VerfasserIn  |4 aut 
700 1 |a Mishkin, Skyler  |e VerfasserIn  |4 aut 
700 1 |a Kudlow, Brian  |e VerfasserIn  |4 aut 
700 1 |a Kaczorowski, Adam  |e VerfasserIn  |0 (DE-588)1062747550  |0 (DE-627)806827742  |0 (DE-576)420146318  |4 aut 
700 1 |a Zschäbitz, Stefanie  |d 1983-  |e VerfasserIn  |0 (DE-588)1037698827  |0 (DE-627)75589894X  |0 (DE-576)391727206  |4 aut 
700 1 |a Volckmar, Anna-Lena  |d 1984-  |e VerfasserIn  |0 (DE-588)173874916  |0 (DE-627)698776666  |0 (DE-576)134713478  |4 aut 
700 1 |a Sültmann, Holger  |d 1962-  |e VerfasserIn  |0 (DE-588)172777291  |0 (DE-627)697708144  |0 (DE-576)133633926  |4 aut 
700 1 |a Jäger, Dirk  |d 1964-  |e VerfasserIn  |0 (DE-588)1032507535  |0 (DE-627)738505323  |0 (DE-576)380074125  |4 aut 
700 1 |a Duensing, Anette  |e VerfasserIn  |0 (DE-588)1186091703  |0 (DE-627)1665366486  |4 aut 
700 1 |a Schirmacher, Peter  |d 1961-  |e VerfasserIn  |0 (DE-588)1020440112  |0 (DE-627)691221197  |0 (DE-576)360427448  |4 aut 
700 1 |a Hohenfellner, Markus  |d 1958-  |e VerfasserIn  |0 (DE-588)133862518  |0 (DE-627)557857988  |0 (DE-576)300155263  |4 aut 
700 1 |a Grüllich, Carsten  |d 1965-  |e VerfasserIn  |0 (DE-588)14101914X  |0 (DE-627)624500985  |0 (DE-576)321797981  |4 aut 
700 1 |a Stenzinger, Albrecht  |e VerfasserIn  |0 (DE-588)139606106  |0 (DE-627)703395238  |0 (DE-576)312432755  |4 aut 
700 1 |a Duensing, Stefan  |d 1967-  |e VerfasserIn  |0 (DE-588)1074044487  |0 (DE-627)830213007  |0 (DE-576)435550098  |4 aut 
773 0 8 |i Enthalten in  |t Cancer immunology immunotherapy  |d Berlin : Springer, 1976  |g 68(2019), 10, Seite 1621-1633  |h Online-Ressource  |w (DE-627)253390443  |w (DE-600)1458489-X  |w (DE-576)072283475  |x 1432-0851  |7 nnas  |a The BRCA2 mutation status shapes the immune phenotype of prostate cancer 
773 1 8 |g volume:68  |g year:2019  |g number:10  |g pages:1621-1633  |g extent:13  |a The BRCA2 mutation status shapes the immune phenotype of prostate cancer 
856 4 0 |u https://doi.org/10.1007/s00262-019-02393-x  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20200204 
992 |a 20200204 
993 |a Article 
993 |a Article 
994 |a 2019 
994 |a 2019 
998 |g 1074044487  |a Duensing, Stefan  |m 1074044487:Duensing, Stefan  |d 910000  |d 910200  |e 910000PD1074044487  |e 910200PD1074044487  |k 0/910000/  |k 1/910000/910200/  |p 21  |y j 
998 |g 139606106  |a Stenzinger, Albrecht  |m 139606106:Stenzinger, Albrecht  |d 910000  |d 912000  |e 910000PS139606106  |e 912000PS139606106  |k 0/910000/  |k 1/910000/912000/  |p 20 
998 |g 14101914X  |a Grüllich, Carsten  |m 14101914X:Grüllich, Carsten  |d 910000  |d 910100  |e 910000PG14101914X  |e 910100PG14101914X  |k 0/910000/  |k 1/910000/910100/  |p 19 
998 |g 133862518  |a Hohenfellner, Markus  |m 133862518:Hohenfellner, Markus  |d 910000  |d 910200  |e 910000PH133862518  |e 910200PH133862518  |k 0/910000/  |k 1/910000/910200/  |p 18 
998 |g 1020440112  |a Schirmacher, Peter  |m 1020440112:Schirmacher, Peter  |d 910000  |d 912000  |e 910000PS1020440112  |e 912000PS1020440112  |k 0/910000/  |k 1/910000/912000/  |p 17 
998 |g 1186091703  |a Duensing, Anette  |m 1186091703:Duensing, Anette  |d 910000  |d 910200  |e 910000PD1186091703  |e 910200PD1186091703  |k 0/910000/  |k 1/910000/910200/  |p 16 
998 |g 1032507535  |a Jäger, Dirk  |m 1032507535:Jäger, Dirk  |d 910000  |e 910000PJ1032507535  |k 0/910000/  |p 15 
998 |g 172777291  |a Sültmann, Holger  |m 172777291:Sültmann, Holger  |d 50000  |e 50000PS172777291  |k 0/50000/  |p 14 
998 |g 173874916  |a Volckmar, Anna-Lena  |m 173874916:Volckmar, Anna-Lena  |d 910000  |d 912000  |e 910000PV173874916  |e 912000PV173874916  |k 0/910000/  |k 1/910000/912000/  |p 13 
998 |g 1037698827  |a Zschäbitz, Stefanie  |m 1037698827:Zschäbitz, Stefanie  |d 910000  |d 910100  |e 910000PZ1037698827  |e 910100PZ1037698827  |k 0/910000/  |k 1/910000/910100/  |p 12 
998 |g 1062747550  |a Kaczorowski, Adam  |m 1062747550:Kaczorowski, Adam  |d 910000  |d 910200  |e 910000PK1062747550  |e 910200PK1062747550  |k 0/910000/  |k 1/910000/910200/  |p 11 
998 |g 140241493  |a Stögbauer, Fabian  |m 140241493:Stögbauer, Fabian  |p 7 
998 |g 112053464X  |a Leichsenring, Jonas  |m 112053464X:Leichsenring, Jonas  |d 910000  |d 912000  |e 910000PL112053464X  |e 912000PL112053464X  |k 0/910000/  |k 1/910000/912000/  |p 6 
998 |g 1204096996  |a Kippenberger, Maximilian  |m 1204096996:Kippenberger, Maximilian  |d 50000  |e 50000PK1204096996  |k 0/50000/  |p 5 
998 |g 1063753686  |a Endris, Volker  |m 1063753686:Endris, Volker  |d 910000  |d 912000  |e 910000PE1063753686  |e 912000PE1063753686  |k 0/910000/  |k 1/910000/912000/  |p 4 
998 |g 1162095288  |a Nientiedt, Cathleen  |m 1162095288:Nientiedt, Cathleen  |d 910000  |d 910100  |e 910000PN1162095288  |e 910100PN1162095288  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 120409747X  |a Keß, Peter  |m 120409747X:Keß, Peter  |d 50000  |e 50000PK120409747X  |k 0/50000/  |p 2 
998 |g 1060844354  |a Jenzer, Maximilian  |m 1060844354:Jenzer, Maximilian  |d 910000  |d 910100  |e 910000PJ1060844354  |e 910100PJ1060844354  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1689231246  |e 3587338183 
999 |a KXP-PPN1689231246  |e 358733613X 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"person":[{"role":"aut","given":"Maximilian","family":"Jenzer","display":"Jenzer, Maximilian"},{"display":"Keß, Peter","family":"Keß","role":"aut","given":"Peter"},{"display":"Nientiedt, Cathleen","family":"Nientiedt","role":"aut","given":"Cathleen"},{"family":"Endris","display":"Endris, Volker","given":"Volker","role":"aut"},{"role":"aut","given":"Maximilian","family":"Kippenberger","display":"Kippenberger, Maximilian"},{"given":"Jonas","role":"aut","family":"Leichsenring","display":"Leichsenring, Jonas"},{"family":"Stögbauer","display":"Stögbauer, Fabian","role":"aut","given":"Fabian"},{"family":"Haimes","display":"Haimes, Josh","role":"aut","given":"Josh"},{"role":"aut","given":"Skyler","family":"Mishkin","display":"Mishkin, Skyler"},{"family":"Kudlow","display":"Kudlow, Brian","given":"Brian","role":"aut"},{"display":"Kaczorowski, Adam","family":"Kaczorowski","given":"Adam","role":"aut"},{"family":"Zschäbitz","display":"Zschäbitz, Stefanie","given":"Stefanie","role":"aut"},{"display":"Volckmar, Anna-Lena","family":"Volckmar","role":"aut","given":"Anna-Lena"},{"role":"aut","given":"Holger","family":"Sültmann","display":"Sültmann, Holger"},{"role":"aut","given":"Dirk","display":"Jäger, Dirk","family":"Jäger"},{"family":"Duensing","display":"Duensing, Anette","role":"aut","given":"Anette"},{"family":"Schirmacher","display":"Schirmacher, Peter","role":"aut","given":"Peter"},{"family":"Hohenfellner","display":"Hohenfellner, Markus","given":"Markus","role":"aut"},{"display":"Grüllich, Carsten","family":"Grüllich","role":"aut","given":"Carsten"},{"family":"Stenzinger","display":"Stenzinger, Albrecht","given":"Albrecht","role":"aut"},{"family":"Duensing","display":"Duensing, Stefan","given":"Stefan","role":"aut"}],"id":{"doi":["10.1007/s00262-019-02393-x"],"eki":["1689231246"]},"physDesc":[{"extent":"13 S."}],"name":{"displayForm":["Maximilian Jenzer, Peter Keß, Cathleen Nientiedt, Volker Endris, Maximilian Kippenberger, Jonas Leichsenring, Fabian Stögbauer, Josh Haimes, Skyler Mishkin, Brian Kudlow, Adam Kaczorowski, Stefanie Zschäbitz, Anna-Lena Volckmar, Holger Sültmann, Dirk Jäger, Anette Duensing, Peter Schirmacher, Markus Hohenfellner, Carsten Grüllich, Albrecht Stenzinger, Stefan Duensing"]},"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"recId":"253390443","id":{"eki":["253390443"],"issn":["1432-0851"],"zdb":["1458489-X"]},"origin":[{"publisherPlace":"Berlin ; Heidelberg","dateIssuedDisp":"1976-","dateIssuedKey":"1976","publisher":"Springer"}],"note":["Gesehen am 15.05.2024","Fortsetzung der Druck-Ausgabe","Ungezählte Beil. ab 52.2003: Supplement"],"pubHistory":["1.1976 -"],"title":[{"title":"Cancer immunology immunotherapy","title_sort":"Cancer immunology immunotherapy","subtitle":"CII"}],"disp":"The BRCA2 mutation status shapes the immune phenotype of prostate cancerCancer immunology immunotherapy","type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"titleAlt":[{"title":"CII"}],"part":{"text":"68(2019), 10, Seite 1621-1633","issue":"10","pages":"1621-1633","year":"2019","volume":"68","extent":"13"}}],"recId":"1689231246","type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title":"The BRCA2 mutation status shapes the immune phenotype of prostate cancer","title_sort":"BRCA2 mutation status shapes the immune phenotype of prostate cancer"}],"origin":[{"dateIssuedKey":"2019","dateIssuedDisp":"23 September 2019"}],"note":["Gesehen am 04.02.2020"]} 
SRT |a JENZERMAXIBRCA2MUTAT2320